The New Tecnis Symfony® Lens (IOL)A Masterpiece In Cataract Care
Leading cataract specialists, Gus Stern MD and Sidney Chang MD, are proud to be among the first ophthalmic surgeons in the region to offer patients the benefits of an exciting new multi-purpose cataract lens implant that can not only help you see clearly at all ranges of vision…but can also correct your Astigmatism at the same time.
It is called the Tecnis Symfony® Intraocular Lens (IOL) implant, the first and only FDA-approved cataract lens of its kind in the U.S. designed to give you a full range of continuous high-quality vision. The breakthrough Symfony® IOL is also the only extended depth of field IOL designed to correct presbyopia by helping you focus on near objects. Dr. Stern and Dr. Chang combine the added benefits of the Symfony® IOL with the safety and precision of our Femtosecond laser technology, which we feel gives patients the optimal cataract experience.
As part of our body’s normal aging process, our eyes begin to lose the ability to focus on near objects, which eventually causes almost all of us to need reading glasses. This is known as presbyopia and usually sets in during our 40’s, when we start noticing a difficulty reading small print. This loss of near focus progresses to the point that nearly all “up-close” vision will require the use of reading glasses.
The FDA’s approval of the Symfony® IOL also includes a Toric version of the lens – the Tecnis Symfony® Toric IOL – for patients with astigmatism. Astigmatism is a common condition that causes the light to enter the eye and focus in more than one point on the retina (back of the eye). This creates a “double vision” effect and can also leave your vision blurry. The added benefit of the Symfony® Toric IOL is that it can correct both presbyopia and astigmatism at the same time.
CATARACT LENS IMPROVES RANGE AND QUALITY OF VISION
In studies conducted by the manufacturer of the Symfony® Lens (Abbott Medical Optics), cataract patients in the Symfony® IOL group achieved greater improvements in intermediate and near vision while maintaining similar distance vision when compared to a standard single focus IOL. Symfony® patients were also less likely to wear prescription eyewear and achieved high overall visual performance in any lighting condition.
However, because not all patients are ideal candidates for this lens implant, patient selection and patient expectations are key to the overall success with the Symfony® lens.
CUSTOMIZING YOUR CATARACT OUTCOMES
The key to our success with lenses like the Symfony® IOL lies in our ability to match your lifestyle, your expectations and your general ocular health with the appropriate lens. No manufactured cataract lens implant is perfect in all of its capabilities, but the Symfony® is a significant improvement in our ability to offer seamless, high quality vision that patients enjoyed in their younger years.
If you enjoy a good book, playing golf, knitting, scanning the internet, or other activities that require vision at various distances, the Symfony® IOL will enable you to live the lifestyle you want.
Fortunately, our surgeons employ the same, safe and proven surgical techniques with the Symfony® IOL that has made cataract surgery the most common and successful surgical procedure performed today. Each year, more than 15 million people just like you have their vision restored through modern-day cataract surgery.
Despite this, every surgical procedure has risks and side effects. Some patients may experience an adjustment period to their new lenses in which they encounter a glare or halos around bright light. This usually goes away over a period of weeks or months.
Although IOLs used in cataract surgery are approved by Medicare and the insurance industry, the additional features of the Symfony® lens that provide a longer range of vision or correct astigmatism are not covered by insurance. So, similar to our other Toric and multifocal IOLs, cataract patients will experience an out-of-pocket expense to use the Symfony® lens over a conventional monofocal IOL.